METHAZOLAMIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for methazolamide and what is the scope of patent protection?
Methazolamide
is the generic ingredient in two branded drugs marketed by Ani Pharms, Applied Anal, Athem, Bausch And Lomb Inc, Mikart, Sandoz, Tagi, and Lederle, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.There are seven drug master file entries for methazolamide. Twelve suppliers are listed for this compound.
Summary for METHAZOLAMIDE
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 8 |
| NDAs: | 8 |
| Drug Master File Entries: | 7 |
| Finished Product Suppliers / Packagers: | 12 |
| Raw Ingredient (Bulk) Api Vendors: | 117 |
| Clinical Trials: | 9 |
| Patent Applications: | 6,425 |
| Drug Prices: | Drug price trends for METHAZOLAMIDE |
| What excipients (inactive ingredients) are in METHAZOLAMIDE? | METHAZOLAMIDE excipients list |
| DailyMed Link: | METHAZOLAMIDE at DailyMed |
Recent Clinical Trials for METHAZOLAMIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Wilderness Medical Society | Phase 4 |
| University of Waterloo | Phase 4 |
| University of British Columbia | Phase 4 |
Medical Subject Heading (MeSH) Categories for METHAZOLAMIDE
Anatomical Therapeutic Chemical (ATC) Classes for METHAZOLAMIDE
US Patents and Regulatory Information for METHAZOLAMIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandoz | METHAZOLAMIDE | methazolamide | TABLET;ORAL | 040036-001 | Jun 30, 1993 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Applied Anal | METHAZOLAMIDE | methazolamide | TABLET;ORAL | 040011-002 | Jul 17, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lederle | NEPTAZANE | methazolamide | TABLET;ORAL | 011721-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Tagi | METHAZOLAMIDE | methazolamide | TABLET;ORAL | 215615-001 | Oct 18, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Mikart | METHAZOLAMIDE | methazolamide | TABLET;ORAL | 040062-001 | Jan 27, 1994 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Lederle | NEPTAZANE | methazolamide | TABLET;ORAL | 011721-002 | Nov 25, 1991 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
